Celltrion Pharm Inc (068760) - Total Liabilities

Latest as of September 2025: ₩319.38 Billion KRW ≈ $216.44 Million USD

Based on the latest financial reports, Celltrion Pharm Inc (068760) has total liabilities worth ₩319.38 Billion KRW (≈ $216.44 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Celltrion Pharm Inc - Total Liabilities Trend (2011–2024)

This chart illustrates how Celltrion Pharm Inc's total liabilities have evolved over time, based on quarterly financial data. Explore how much of Celltrion Pharm Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Celltrion Pharm Inc Competitors by Total Liabilities

The table below lists competitors of Celltrion Pharm Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Regis Healthcare Ltd AU:REG	Australia	AU$2.12 Billion
Rio2 Ltd TO:RIO	Canada	CA$345.10 Million
Collective Mining Ltd TO:CNL	Canada	CA$12.92 Million
Edifier Technology Co Ltd SHE:002351	China	CN¥489.23 Million
Cosmo Pharmaceuticals N.V F:C43	Germany	€123.46 Million
Beijing Creative Distribution Automation Co Ltd SHE:002350	China	CN¥1.28 Billion
Ribo Fashion Group Co Ltd SHG:603196	China	CN¥384.04 Million
Darbond Technology Co. Ltd. A SHG:688035	China	CN¥1.03 Billion

Liability Composition Analysis (2011–2024)

This chart breaks down Celltrion Pharm Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Celltrion Pharm Inc assets under control.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.61	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.75	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.43	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Celltrion Pharm Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Celltrion Pharm Inc (2011–2024)

The table below shows the annual total liabilities of Celltrion Pharm Inc from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩272.54 Billion ≈ $184.70 Million	+2.85%
2023-12-31	₩264.98 Billion ≈ $179.57 Million	+9.07%
2022-12-31	₩242.94 Billion ≈ $164.64 Million	-20.59%
2021-12-31	₩305.92 Billion ≈ $207.31 Million	+23.60%
2020-12-31	₩247.51 Billion ≈ $167.74 Million	+29.62%
2019-12-31	₩190.95 Billion ≈ $129.40 Million	+4.68%
2018-12-31	₩182.41 Billion ≈ $123.62 Million	+3.26%
2017-12-31	₩176.65 Billion ≈ $119.71 Million	+6.82%
2016-12-31	₩165.37 Billion ≈ $112.07 Million	-28.27%
2015-12-31	₩230.54 Billion ≈ $156.23 Million	+17.18%
2014-12-31	₩196.74 Billion ≈ $133.33 Million	+1.97%
2013-12-31	₩192.94 Billion ≈ $130.75 Million	+11.01%
2012-12-31	₩173.80 Billion ≈ $117.78 Million	+97.92%
2011-12-31	₩87.81 Billion ≈ $59.51 Million	--

About Celltrion Pharm Inc

KQ:068760 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$1.32 Billion

₩1.95 Trillion KRW

Market Cap Rank

#7746 Global

#200 in Korea

Share Price

₩45000.00

Change (1 day)

+1.81%

52-Week Range

₩38000.00 - ₩75700.00

All Time High

₩222138.48